Inhaled Nitric Oxide Market Size & Share, By Product Type (Gas, Delivery system), Application (Neonatal Respiratory Treatment, Asthma and COPD, Acute Respiratory Distress Syndrome, Malaria Treatment, Tuberculosis Treatment) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034
Market Outlook
Market Size and Growth Outlook
Inhaled Nitric Oxide Market size is expected to expand from USD 1.1 billion in 2024 to USD 2.35 billion by 2034, demonstrating a CAGR of more than 7.9% between 2025 and 2034. In 2025, the industry revenue is estimated to reach USD 1.18 billion.
Base Year Value (2024)
USD 1.1 billion
CAGR (2025-2034)
7.9%
Forecast Year Value (2034)
USD 2.35 billion
Historical Data Period
2019-2024
Largest Region
North America
Forecast Period
2025-2034
Get more details on this report
Request Free Sample Report SNAPSHOT
Inhaled Nitric Oxide Market Intelligence Snapshot
Regional Market Dynamics
Segment Momentum
Market Expansion Drivers
Leading Market Participants
FORECAST SNAPSHOT
Global Market Forecast Snapshot
Market Outlook
Regional and Segment Outlook
REGIONAL FORECAST
Regional Demand Dynamics
Largest Region
North America
32% Market Share in 2024
SEGMENT ANALYSIS
Segment Leadership and Growth Trends
Go beyond the chart, access full insights & data tables
Request Free Sample Report
Inhaled Nitric Oxide Market Segment Analysis
By Product Type
The inhaled nitric oxide market can be segmented into two primary product types: gas and delivery systems. The gas segment remains the most significant, driven by its essential role in therapeutic applications. Inhaled nitric oxide gas is critical for managing various respiratory conditions due to its potent vasodilatory effects. The delivery system segment, although smaller, is gaining momentum as advancements in technology improve the accuracy and efficiency of administering inhaled nitric oxide. Devices designed for precise delivery are crucial for ensuring patient safety and treatment efficacy, making them a vital component in the market's growth.
By Application
The application of inhaled nitric oxide is diverse, encompassing neonatal respiratory treatment, asthma and COPD, acute respiratory distress syndrome, malaria treatment, and tuberculosis treatment. Neonatal respiratory treatment represents the largest segment, as the use of inhaled nitric oxide has significantly improved outcomes for preterm infants suffering from hypoxic respiratory failure. The asthma and COPD segment is also expanding, attributed to the rising prevalence of these chronic conditions and the efficacy of nitric oxide in alleviating airway constriction. Acute respiratory distress syndrome (ARDS) applications are witnessing increased adoption as inhaled nitric oxide can reduce pulmonary hypertension and improve oxygenation in critically ill patients. Moreover, the exploration of inhaled nitric oxide's potential in treating malaria and tuberculosis highlights its versatility and the ongoing research to broaden its therapeutic uses. This diverse application range indicates a robust growth trajectory for the inhaled nitric oxide market across various patient demographics and medical conditions.
Competitive Landscape
Competitive Landscape and Market Positioning
The inhaled nitric oxide market is characterized by intense competition, driven by the increasing prevalence of respiratory diseases and the growing demand for nitric oxide as a therapeutic agent in neonatal and adult respiratory care. Key players in this market focus on the development of innovative delivery systems and improving the efficacy of inhaled nitric oxide treatments. The competitive landscape is also shaped by strategic collaborations, mergers, and acquisitions, as companies strive to enhance their market share and expand their product portfolios. Regulatory approval for new formulations and delivery methods plays a significant role in determining competitive advantage. Additionally, the presence of generic products has intensified competition, forcing leading manufacturers to invest in research and development to differentiate their offerings.
Top Market Players
- Mallinckrodt Pharmaceuticals
- INO Therapeutics
- Air Liquide
- Praxair
- Advanced Speciality Gases
- Healthcare Solutions
- DuraSource
- Vero Biotech
- Rejuvenair
- Bellerophon Therapeutics
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry News
Industry Development/News
| Company Name | Date | Key Development |
|---|
Report Customization
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Inhaled Nitric Oxide Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| No segment data available. | |
Inhaled Nitric Oxide Market — Custom
| Custom Chapter | Custom Details | ||
|---|---|---|---|
| No custom TOC data available. | |||
Need a different cut of the data?
Request Custom Research
Frequently Asked Questions
Testimonials
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
Quality Assurance Manager
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
R&D Manager
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Senior Marketing Manager
THE RESEARCH BEHIND THIS REPORT
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
THIS REPORT'S RESEARCH VERTICAL
Research Team Overview
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.
Prepared by the Healthcare & Medical Devices Research Team
10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
Delivery
12k+
Research Reports
Published
Published
On-
Demand
Demand
Customized Research
Available
Available
6
Months Analyst
Support
Support
PDF + XLS
Report Deliverables
Trust & Compliance
☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling
Research Domains
10 coverage areas
Medical Devices & Equipment
Diagnostic Imaging
Clinical Diagnostics
Digital Health & Telemedicine
Patient Monitoring Systems
Surgical & Minimally Invasive Technologies
Healthcare IT & Data Systems
Biotechnology & Life Sciences
Pharmaceutical Technologies
Healthcare Delivery & Services
Research Intelligence
Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts
| Source | Why It Matters | Reference |
|---|---|---|
| World Health Organization (WHO) | Global health statistics, disease burden, healthcare policies | www.who.int |
| U.S. Food & Drug Administration (FDA) | Medical devices, pharmaceuticals, diagnostics, approvals | www.fda.gov |
| European Medicines Agency (EMA) | Pharmaceutical approvals and regulatory guidance in Europe | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | Disease surveillance, public health, epidemiology | www.cdc.gov |
| National Institutes of Health (NIH) | Biomedical research, clinical studies, funding | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | Biomedical databases, PubMed, genomics | www.ncbi.nlm.nih.gov |
| PubMed | Peer-reviewed biomedical literature | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | Global clinical trial registry | clinicaltrials.gov |
| International Organization for Standardization (ISO) | Medical device quality and healthcare standards | www.iso.org |
| ASTM International | Medical device testing and material standards | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | Medical devices and diagnostics industry | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | Medical device innovation and regulatory science | mdic.org |
| Biotechnology Innovation Organization (BIO) | Biotechnology industry developments | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | Global pharmaceutical industry | www.ifpma.org |
| U.S. Pharmacopeia (USP) | Drug quality standards and reference materials | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | European pharmaceutical quality standards | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | Veterinary healthcare and animal diseases | www.woah.org |
| American Hospital Association (AHA) | Hospital operations and healthcare delivery | www.aha.org |
| OECD Health | International healthcare expenditure and system statistics | www.oecd.org/health |
| World Bank Data | Healthcare expenditure and demographic indicators | data.worldbank.org |
Research Workflow & Quality Assurance
01
Data Collection
Verified information gathered through primary and secondary research.
02
Data Triangulation
Cross-validation using multiple independent data sources.
03
Forecast Modelling
Market estimates developed using historical trends and analytical models.
04
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
05
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
06
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization
About This Report